AI drug discovery platform Insilico Medicine announces $255 million in Series C funding
TechCrunch
JUNE 22, 2021
Insilico Medicine, an AI-based platform for drug development and discovery, announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the company: proof that its AI-based platform can create a new target for a disease, develop a bespoke molecule to address it and begin the clinical trial process. .
Let's personalize your content